{"symbol": "MGTX", "companyName": "MeiraGTx Holdings plc", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.meiragtx.com", "description": "MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.", "CEO": "Alexandria Forbes", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}